These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3304372)

  • 1. Felodipine in patients with chronic heart failure: discrepant haemodynamic and clinical effects.
    Tan LB; Murray RG; Littler WA
    Br Heart J; 1987 Aug; 58(2):122-8. PubMed ID: 3304372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of felodipine in congestive heart failure.
    Dunselman PH; Kuntze CE; van Bruggen A; Hamer JP; Scaf AH; Wessling H; Lie KI
    Eur Heart J; 1989 Apr; 10(4):354-64. PubMed ID: 2656266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of felodipine in chronic congestive heart failure: a placebo controlled haemodynamic study at rest and during exercise and orthostatic stress.
    Kassis E; Amtorp O; Waldorff S; Fritz-Hansen P
    Br Heart J; 1987 Nov; 58(5):505-11. PubMed ID: 3314956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained haemodynamic effects of felodipine in patients with chronic cardiac failure.
    Tweddel AC; Martin W; McGhie AI; Hutton I
    Br J Clin Pharmacol; 1988 Jun; 25(6):689-94. PubMed ID: 3203040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and neurohumoral postural responses and baroreceptor abnormalities during a course of adjunctive vasodilator therapy with felodipine for congestive heart failure.
    Kassis E; Amtorp O
    Circulation; 1987 Jun; 75(6):1204-13. PubMed ID: 2882868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of treatment with felodipine as a single agent in coronary artery disease.
    Metcalfe MJ; Chan-Wah-Hak NS; Jennings K
    Br Heart J; 1989 Mar; 61(3):258-61. PubMed ID: 2649120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.
    Boden WE; Ziesche S; Carson PE; Conrad CH; Syat D; Cohn JN
    Am J Cardiol; 1996 May; 77(12):1078-82. PubMed ID: 8644661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamic effects of felodipine in congestive heart failure.
    Held P; Swedberg K
    Drugs; 1987; 34 Suppl 3():81-4. PubMed ID: 3443068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial vasodilator therapy in heart failure: haemodynamic response patterns predictive of changes in exercise capacity.
    Tan LB; Fox Y; Littler WA
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):862-8. PubMed ID: 2481774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic effects of felodipine during supine resting and exercising states and orthostatic tilt in patients with chronic congestive heart failure.
    Kassis E; Waldorff S; Amtorp O
    Drugs; 1987; 34 Suppl 3():69-70. PubMed ID: 3443067
    [No Abstract]   [Full Text] [Related]  

  • 11. Felodipine in ischaemic heart disease.
    Sheridan JV; Thomas P; Sheridan DJ
    Drugs; 1987; 34 Suppl 3():71-8. PubMed ID: 3327683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group.
    Cohn JN; Ziesche S; Smith R; Anand I; Dunkman WB; Loeb H; Cintron G; Boden W; Baruch L; Rochin P; Loss L
    Circulation; 1997 Aug; 96(3):856-63. PubMed ID: 9264493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium channel blocker and isosorbide 5-mononitrate in the management of chronic cardiac failure.
    Hutton I; McGhie AI; Martin W; Tweddel AC
    Cardiology; 1987; 74 Suppl 1():72-5. PubMed ID: 3607808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of felodipine on plasma digoxin levels and haemodynamics in patients with heart failure.
    Kirch W; Laskowski M; Ohnhaus EE; Aberg J
    J Intern Med; 1989 Apr; 225(4):237-9. PubMed ID: 2656902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Felodipine in heart failure. A double-blind, randomised, placebo-controlled parallel-group study in 23 patients.
    Dunselman PH; Kuntze CE; van Bruggen A; Lie KI
    Drugs; 1987; 34 Suppl 3():79-80. PubMed ID: 3327684
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of vasodilator treatment with felodipine on haemodynamic responses to treadmill exercise in congestive heart failure.
    Timmis AD; Smyth P; Kenny JF; Campbell S; Jewitt DE
    Br Heart J; 1984 Sep; 52(3):314-20. PubMed ID: 6466518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different results in cardiopulmonary exercise tests after long-term treatment with felodipine and enalapril in patients with congestive heart failure due to ischaemic heart disease.
    Dunselman PH; van der Mark TW; Kuntze CE; van Bruggen A; Hamer JP; Scaf AH; Wesseling H; Lie KI
    Eur Heart J; 1990 Mar; 11(3):200-6. PubMed ID: 2318222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central and peripheral haemodynamic responses to felodipine in congestive heart failure.
    Capewell S; Wathen CG; Muir AL
    Eur J Clin Pharmacol; 1991; 41(2):95-8. PubMed ID: 1743253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentration-effect relationship of felodipine intravenously in patients with congestive heart failure.
    Dunselman PH; Edgar B; Scaf AH; Kuntze CE; van Bruggen A; Lie KI; Wesseling H
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):438-43. PubMed ID: 2476624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of felodipine on haemodynamics and exercise capacity in patients with angina pectoris.
    Sheridan JV; Thomas P; Routledge PA; Sheridan DJ
    Br J Clin Pharmacol; 1987 Apr; 23(4):391-6. PubMed ID: 3107605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.